Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?

CVS Health CVS reported its second-quarter 2025 results last week, wherein adjusted operating income (AOI) rose 2% year over year to approximately $3.80 billion. This was supported by 39.4% AOI

Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed
Ashland Q3 Earnings and Sales Lag Estimates, Guidance Narrowed

Ashland Global Holdings Inc. ASH recorded a loss of $742 million or $16.21 per share in third-quarter fiscal 2025 (ended June 30) compared with a profit of $6 million or 12 cents in the prior-year

Can Oklo's Fuel Recycling Strategy Change Nuclear Power?
Can Oklo's Fuel Recycling Strategy Change Nuclear Power?

Oklo Inc. OKLO is rethinking how nuclear energy is produced, and at the center of its strategy is fuel recycling. Unlike conventional reactors that only use about 5% of the energy content from

UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates
UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates

UL Solutions Inc. (ULS) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.44 per share a year ago. These

Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates

Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.24 per share a year ago. These figures are

Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates

Madrigal (MDGL) came out with a quarterly loss of $1.9 per share versus the Zacks Consensus Estimate of a loss of $3.48. This compares to a loss of $7.1 per share a year ago. These figures are

Sealed Air (SEE) Q2 Earnings and Revenues Beat Estimates
Sealed Air (SEE) Q2 Earnings and Revenues Beat Estimates

Sealed Air (SEE) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.83 per share a year ago. These figures

Knife River (KNF) Misses Q2 Earnings and Revenue Estimates
Knife River (KNF) Misses Q2 Earnings and Revenue Estimates

Knife River (KNF) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.37 per share a year ago. These figures

LCI (LCII) Q2 Earnings and Revenues Top Estimates
LCI (LCII) Q2 Earnings and Revenues Top Estimates

LCI (LCII) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.4 per share a year ago. These figures are

Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates

Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $1.11 per share a year ago. These

AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago. These

J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates
J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates

J&J Snack Foods (JJSF) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.98 per share a year ago. These

Fidelity National Information Services (FIS) Matches Q2 Earnings Estimates
Fidelity National Information Services (FIS) Matches Q2 Earnings Estimates

Fidelity National Information Services (FIS) came out with quarterly earnings of $1.36 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.36 per share a year ago

Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates
Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates

Cushman & Wakefield (CWK) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.2 per share a year ago. These

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. These figures are

AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates

AC Immune (ACIU) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.25 per share a year ago. These figures are

Axcelis Technologies (ACLS) Tops Q2 Earnings and Revenue Estimates
Axcelis Technologies (ACLS) Tops Q2 Earnings and Revenue Estimates

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $1.55 per share a year ago

Grab These 4 Stocks With Solid Net Profit Margin to Enhance Returns
Grab These 4 Stocks With Solid Net Profit Margin to Enhance Returns

Investors prefer to invest in businesses that reap profits on a regular basis. To gauge the extent of profits, there is no better metric than the net profit margin.

A higher net margin reflects a

Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates

Zoetis (ZTS) came out with quarterly earnings of $1.76 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.56 per share a year ago. These figures are

Yum Brands (YUM) Misses Q2 Earnings Estimates
Yum Brands (YUM) Misses Q2 Earnings Estimates

Yum Brands (YUM) came out with quarterly earnings of $1.44 per share, missing the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.35 per share a year ago. These figures

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue EstimatesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to a loss of $0.55 per share a year ago

Spire (SR) Surpasses Q3 Earnings and Revenue Estimates
Spire (SR) Surpasses Q3 Earnings and Revenue Estimates

Spire (SR) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to a loss of $0.14 per share a year ago. These

Marriott International (MAR) Surpasses Q2 Earnings and Revenue Estimates
Marriott International (MAR) Surpasses Q2 Earnings and Revenue Estimates

Marriott International (MAR) came out with quarterly earnings of $2.65 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $2.5 per share a year ago

Archer Daniels Midland (ADM) Q2 Earnings and Revenues Top Estimates
Archer Daniels Midland (ADM) Q2 Earnings and Revenues Top Estimates

Archer Daniels Midland (ADM) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $1.03 per share a year ago

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.45 per share a year ago